Medicare Enrolled

Dr. Laura Divine, M.D.

Gynecologic Oncology Physician · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3410 WORTH ST STE 400, Dallas, TX 75246
2143701300
In practice since 2010 (15 years)
NPI: 1255659173 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Divine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Divine? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Divine

Dr. Laura Divine is a gynecologic oncology physician in Dallas, TX, with 15 years in practice. Based on federal Medicare data, Dr. Divine performed 2,454 Medicare services across 486 unique beneficiaries.

Between the years covered by Open Payments, Dr. Divine received a total of $3,764 from 8 pharmaceutical and/or device companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Divine is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 11% volume in TX$ $3,764 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,454
Medicare services
Top 11% in TX for gynecologic oncology physician
486
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~164 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)1,070$0$3
Blood draw (venipuncture)276$8$20
Comprehensive metabolic blood panel240$10$64
Complete blood count (CBC) with differential237$8$36
Immunologic analysis for detection of tumor antigen, quantitative; ca 125193$20$128
Office visit, established patient (30-39 min)166$91$368
Office visit, established patient (20-29 min)73$64$250
Urinalysis with microscopic exam70$3$28
Office visit, established patient, complex (40-54 min)55$134$496
New patient office visit (45-59 min)23$120$565
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less15$674$3,096
Ct scan of chest with contrast13$51$821
CT scan of abdomen and pelvis with contrast12$187$1,067
Imaging of lymph nodes during surgery11$157$874
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
44.6% medium
54.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,764
Total received (2018-2024)
Avg $627/year across 6 years
Top 42% in TX for gynecologic oncology physician
8
Companies
35
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,662 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$102 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$176
2023
$2,003
2022
$252
2020
$56
2019
$1,179
2018
$98

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$2,808
AstraZeneca Pharmaceuticals LP
$506
Myriad Genetic Laboratories, Inc.
$149
Clovis Oncology, Inc.
$102
Merck Sharp & Dohme Corporation
$97
Merck Sharp & Dohme LLC
$47
Innovation Technologies Inc
$37
GlaxoSmithKline, LLC.
$17
Top 3 companies account for 92.0% of total payments
Associated products mentioned in payments ›
DA VINCI SP · Da Vinci Surgical System · IRRISEPT · KEYTRUDA · LYNPARZA · PreciseTumor · Rubraca · ZEJULA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $153 per 100 Medicare services performed
Looking for a gynecologic oncology physician in Dallas?
Compare gynecologic oncology physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse gynecologic oncology physicians nearby

Geographic Context

Gynecologic Oncology Physicians within 10 mi
17
Per 100K population
0.7
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Divine is a mixed practice specialist, with above-average Medicare volume (top 11% in TX), and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Divine experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Divine performed 1,070 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Divine receive payments from pharmaceutical companies?
Yes. Dr. Divine received a total of $3,764 from 8 companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Divine's costs compare to other gynecologic oncology physicians in Dallas?
Dr. Divine's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Divine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →